Turnstone Biologics Corp.

NasdaqGM:TSBX Stock Report

Market Cap: US$8.6m

Turnstone Biologics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of TSBX?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders885,6323.83%
Public Companies895,8243.87%
Hedge Funds1,484,3446.42%
VC/PE Firms6,480,95728%
Institutions6,640,50528.7%
General Public6,741,19229.1%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 70.68% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
14.6%
Versant Venture Management, LLC
3,381,692US$1.3m0%0.58%
13.4%
OrbiMed Advisors LLC
3,099,265US$1.2m0%0.02%
6.42%
Point72 Asset Management, L.P.
1,484,344US$551.9k0.14%no data
4.9%
Impresa Management LLC
1,133,987US$421.6k0%0.35%
4.41%
FACIT Inc.
1,020,636US$379.5k0%no data
4.03%
PFM Health Sciences, LP
932,348US$346.6k0%0.03%
3.87%
Takeda Pharmaceutical Company Limited
895,824US$333.1k0%no data
3.85%
Bank of America Corporation, Asset Management Arm
891,526US$331.5k0%no data
3.83%
Timothy Langer
885,632US$329.3k0%no data
2.98%
Citadel Advisors LLC
689,213US$256.2k0%no data
2.5%
The Vanguard Group, Inc.
578,995US$215.3k0%no data
2.24%
Sectoral Asset Management Inc.
517,648US$192.5k0%0.04%
0.83%
Fidelity International Ltd
192,657US$71.6k0%no data
0.6%
Geode Capital Management, LLC
138,659US$51.6k4.4%no data
0.49%
Barclays PLC Private Banking & Investment Banking Investment
114,058US$42.4k3.65%no data
0.32%
Millennium Management LLC
73,744US$27.4k-28.4%no data
0.29%
Susquehanna International Group, LLP, Asset Management Arm
67,324US$25.0k0%no data
0.27%
Citigroup Inc.,Banking and Securities Investments
61,413US$22.8k0%no data
0.22%
FMR LLC
50,056US$18.6k28.4%no data
0.19%
BlackRock, Inc.
43,192US$16.1k0.61%no data
0.1%
Renaissance Technologies LLC
23,900US$8.9k0%no data
0.089%
Goldman Sachs Group, Investment Banking and Securities Investments
20,518US$7.6k0%no data
0.08%
Northern Trust Global Investments
18,405US$6.8k0%no data
0.077%
Acadian Asset Management LLC
17,833US$6.6k-51.1%no data
0.066%
BNP Paribas Arbitrage Sa, Asset Management Arm
15,238US$5.7k0%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/03/17 14:49
End of Day Share Price 2025/03/14 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Turnstone Biologics Corp. is covered by 4 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Geoffrey MeachamBofA Global Research
Charlie YangBofA Global Research
Daina GrayboschLeerink Partners LLC